UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 60

Sortiert nach

All‐oral direct‐acting antiviral therapy in HCV‐advanced liver disease is effective in real‐world practice: observations through HCV‐TARGET database

Alimentary pharmacology & therapeutics, 2017-01, Vol.45 (1), p.115-126

2017

Volltextzugriff (PDF)

Inhibition of c3 convertase activity by hepatitis C virus as an additional lesion in the regulation of complement components

PloS one, 2014-07, Vol.9 (7), p.e101422-e101422

2014

Volltextzugriff (PDF)

Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patients

PloS one, 2010-02, Vol.5 (2), p.e9032

2010

Volltextzugriff (PDF)

High-resolution quantification of hepatitis C virus genome-wide mutation load and its correlation with the outcome of peginterferon-alpha2a and ribavirin combination therapy

PloS one, 2014-06, Vol.9 (6), p.e100131

2014

Volltextzugriff (PDF)

Altered functionality of anti-bacterial antibodies in patients with chronic hepatitis C virus infection

PloS one, 2013-06, Vol.8 (6), p.e64992-e64992

2013

Volltextzugriff (PDF)

Changes in quality of life and sexual health are associated with low‐dose peginterferon therapy and disease progression in patients with chronic hepatitis C

Alimentary pharmacology & therapeutics, 2010-04, Vol.31 (7), p.719-734

2010

Volltextzugriff (PDF)

Prevention of Hepatocellular Carcinoma Resulting From Hepatitis B: Are We There Yet?

Clinical gastroenterology and hepatology, 2014-05, Vol.12 (5), p.894-896

Di Bisceglie, Adrian M., MD, FACP

2014

Volltextzugriff (PDF)

Long‐term clinical and histopathological follow‐up of chronic posttransfusion hepatitis

Hepatology (Baltimore, Md.), 1991-12, Vol.14 (6), p.969-974

1991

Volltextzugriff (PDF)

Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults

Vaccine, 2010-08, Vol.28 (38), p.6367-6373

2010

Volltextzugriff (PDF)

Complication Rate of Percutaneous Liver Biopsies Among Persons With Advanced Chronic Liver Disease in the HALT-C Trial

Clinical gastroenterology and hepatology, 2010-10, Vol.8 (10), p.877-883

2010

Volltextzugriff (PDF)

A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients

Oncology reports, 2006-07, Vol.16 (1), p.133-140

2006

Volltextzugriff (PDF)

Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level Viremia

The American journal of gastroenterology, 2019-11, Vol.114 (11), p.1753-1763

2019

Volltextzugriff (PDF)

Characteristics of Adults in the Hepatitis B Research Network in North America Reflect Their Country of Origin and Hepatitis B Virus Genotype

Clinical gastroenterology and hepatology, 2015, Vol.13 (1), p.183-192

2015

Volltextzugriff (PDF)

Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir

Alimentary pharmacology & therapeutics, 2015-04, Vol.41 (7), p.671-685

2015

Volltextzugriff (PDF)

Frequency of Elevated Hepatocellular Carcinoma (HCC) Biomarkers in Patients With Advanced Hepatitis C

The American journal of gastroenterology, 2012-01, Vol.107 (1), p.64-74

2012

Volltextzugriff (PDF)

Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis

Journal of hepatology, 2007-03, Vol.46 (3), p.420-431

2007

Volltextzugriff (PDF)

Infection with Hepatitis C Virus Genotype 4 in the United States

Journal of clinical gastroenterology, 2004-01, Vol.38 (1), p.68-71

2004

Volltextzugriff (PDF)

Patient engagement and study design of PROP UP: A multi-site patient-centered prospective observational study of patients undergoing hepatitis C treatment

Contemporary clinical trials, 2017-06, Vol.57, p.58-68

2017

Volltextzugriff (PDF)

Hepatitis C–related hepatocellular carcinoma in the United States: influence of ethnic status

The American journal of gastroenterology, 2003-09, Vol.98 (9), p.2060-2063

2003

Volltextzugriff (PDF)

Reduction in Hepatic Inflammation Is Associated With Less Fibrosis Progression and Fewer Clinical Outcomes in Advanced Hepatitis C

The American journal of gastroenterology, 2012-09, Vol.107 (9), p.1388-1398

2012

Volltextzugriff (PDF)

Comparison of genetic heterogeneity of hepatitis C viral RNA in liver tissue and serum

The American journal of gastroenterology, 1999-05, Vol.94 (5), p.1347-1354

1999

Volltextzugriff (PDF)

VX-222, a non-nucleoside NS5B polymerase inhibitor, in telaprevir-based regimens for genotype 1 hepatitis C virus infection

European journal of gastroenterology & hepatology, 2014-07, Vol.26 (7), p.761-773

2014

Volltextzugriff (PDF)

The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosis

Gastrointestinal endoscopy, 2006-12, Vol.64 (6), p.855-864

2006

Volltextzugriff (PDF)

Development of Hepatocellular Carcinoma Among Patients with Chronic Liver Disease due to Hepatitis C Viral Infection

Journal of clinical gastroenterology, 1994-10, Vol.19 (3), p.222-226

1994

Volltextzugriff (PDF)

A comparison of statistical methods for the detection of hepatocellular carcinoma based on serum biomarkers and clinical variables

BMC medical genomics, 2013, Vol.6 Suppl 3 (S3), p.S9-S9, Article S9

2013

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Aktive Filter

KollektionIEEE Xplore Digital Library

Zeitschrift / SerieGastroenterology

KollektionIngentaConnect Journals

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(60)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(60)
Science & Technology
(55)
Female
(50)
Life Sciences & Biomedicine
(50)
Middle Aged
(46)
Adult
(41)
Biological And Medical Sciences
(35)
Medical Sciences
(35)
Gastroenterology & Hepatology
(31)
Aged
(26)
Infectious Diseases
(16)
Viral Diseases
(15)
Gastroenterology. Liver. Pancreas. Abdomen
(14)
Human Viral Diseases
(14)
Viral Hepatitis
(14)
Antiviral Agents - Therapeutic Use
(13)
Hepatitis C Virus
(12)
Hepatitis C, Chronic - Drug Therapy
(12)
Adolescent
(10)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

All‐oral direct‐acting antiviral therapy in HCV‐advanced liver disease is effective in real‐world practice: observations through HCV‐TARGET database

Inhibition of c3 convertase activity by hepatitis C virus as an additional lesion in the regulation of complement components

Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patients

High-resolution quantification of hepatitis C virus genome-wide mutation load and its correlation with the outcome of peginterferon-alpha2a and ribavirin combination therapy

Altered functionality of anti-bacterial antibodies in patients with chronic hepatitis C virus infection

Changes in quality of life and sexual health are associated with low‐dose peginterferon therapy and disease progression in patients with chronic hepatitis C

Prevention of Hepatocellular Carcinoma Resulting From Hepatitis B: Are We There Yet?

Long‐term clinical and histopathological follow‐up of chronic posttransfusion hepatitis

Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults

Complication Rate of Percutaneous Liver Biopsies Among Persons With Advanced Chronic Liver Disease in the HALT-C Trial

A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients

Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level Viremia

Characteristics of Adults in the Hepatitis B Research Network in North America Reflect Their Country of Origin and Hepatitis B Virus Genotype

Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir

Frequency of Elevated Hepatocellular Carcinoma (HCC) Biomarkers in Patients With Advanced Hepatitis C

Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis

Infection with Hepatitis C Virus Genotype 4 in the United States

Patient engagement and study design of PROP UP: A multi-site patient-centered prospective observational study of patients undergoing hepatitis C treatment

Hepatitis C–related hepatocellular carcinoma in the United States: influence of ethnic status

Reduction in Hepatic Inflammation Is Associated With Less Fibrosis Progression and Fewer Clinical Outcomes in Advanced Hepatitis C

Comparison of genetic heterogeneity of hepatitis C viral RNA in liver tissue and serum

VX-222, a non-nucleoside NS5B polymerase inhibitor, in telaprevir-based regimens for genotype 1 hepatitis C virus infection

The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosis

Development of Hepatocellular Carcinoma Among Patients with Chronic Liver Disease due to Hepatitis C Viral Infection

A comparison of statistical methods for the detection of hepatocellular carcinoma based on serum biomarkers and clinical variables

Aktive Filter

Suchergebnisse filtern